Static and Dynamic Core Stability Exercises in Potpartum Back Pain
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Apr 15, 2022
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
The study comprised 28 participants. The individuals were subdivided into binary groups, group A performed static exercises and group B performed dynamic exercises including swiss ball, each containing 14 subjects. Baseline treatment (Hot pack, TENS and posture correction) to both groups was given along with core stability exercises. Core stability exercises were performed on both group for 4 weeks. The pretreatment and post treatment tests are measured using the scale VAS (visual analog scale) and Oswestry disability index questionnaire. Both groups have shown the improvement in postpartum...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age groups of 18 to 35
- • Pain more than 4/10 on VAS
- • Without referred pain to lower limbs
- • Women with normal delivery
- Exclusion Criteria:
- • Nulliparous women
- • Osteoporosis and OA
- • Systemic arterial hypertension
- • Hypersensitivity to electrical modalities
- • Any fracture (spine, rib) or injury
- • Any abdominal surgery
- • Any other general ailment
- • Vertebral or disc pathologies
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Sara Aabroo, pp-dpt
Principal Investigator
General hospital lahore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials